Notalgia Paresthetica (NP) Case Study

Click here for a PDF version of this case study

PPP rescue case study

 

Study Characteristics

  • Study Phase: II
  • Patient Population: 126 patients with Notalgia Paresthetica (NP) (Pruritus associated with NP)
  • IP Route of Administration: Systemic (oral)
  • Site Distribution: 33 sites (USA and Canada)
  • Study Procedures: Photographs, Pharmacokinetics, Electrocardiograms

 


 

Study Challenges

  • Patient awareness: Challenge in advertisement as patients are often unaware of the name of their condition
  • Run-in period (screening): To ensure the enrollment of highly compliant patients and those with consistent itch
  • Patient compliance: Primary endpoints were relying on patient-reported assessments
  • Uncommon indication: PI with little experience in this indication
  •  


     

    Study Highlights

    Site engagement Increased support for low-performing sites

    Engaged with low-enrolling sites to ensure proper use of their local campaign budget

    Phone interview icon Creative advertising

    Digital and local innovative marketing tactics to encourage patients to participate

    Dermatology Investigator Icon Notalgia paresthetica cro specialty

    Innovaderm managed 100% of the notalgia paresthetica studies (as per clinical trials.gov)

    Dermatology Investigator Icon High compliance rate

    Additional patient compensation for fully completed diary

     

     

    Contact us

    Innovaderm Research Wave